patent/ZA-200307575-B

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fc6c2e9e63b6561f2f46b1de31f6379
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P-
filingDate	2003-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44773e18820af51f8e40ff13c122a4d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2b4b02e898a8a715dfd1dad84791f28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b282d238a28876ccac654d5d2275cd0c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3daf540760e86f44152f4dafe03e5f2e
publicationDate	2005-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	ZA-200307575-B
titleOfInvention	Orally deliverable pharmaceutical composition comprising a drug of low water solubility (cox-2inhibitor), a solvent, a fatty acid and an organic amine.
priorityDate	2001-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 15.